title: Clinical experience with lower doses of cefotaxime in hospitalized patients with serious infections.
authors.affiliation: Cefotaxime (Claforan) is manufactured by Hoechst-Roussel Pharmaceuticals Inc., Somerville, New Jersey, USA.
authors.forename: A
authors.initials: A
authors.lastname: Shah
authors.forename: T
authors.initials: T
authors.lastname: Madhavan
authors.forename: V
authors.initials: V
authors.lastname: Drelichman
authors.forename: J
authors.initials: J
authors.lastname: Price
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D001424:Bacterial Infections / Q000145:classification / Q000188:drug therapy*; D002439:Cefotaxime / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D007262:Infusions, Intravenous; D007297:Inpatients; D008824:Michigan; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002439:Cefotaxime